204 related articles for article (PubMed ID: 28146080)
1. Whole Exome Sequencing in Psoriasis Patients Contributes to Studies of Acitretin Treatment Difference.
Zhou X; He Y; Kuang Y; Li J; Zhang J; Chen M; Chen W; Su J; Zhao S; Liu P; Chen M; Shen M; Chen X; Zhu W; Chen X
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146080
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of SLCO1B1 rs4149056 and SLC22A1 rs2282143 are associated with responsiveness to acitretin in psoriasis patients.
Chen W; Zhang X; Zhang W; Peng C; Zhu W; Chen X
Sci Rep; 2018 Sep; 8(1):13182. PubMed ID: 30181619
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E gene polymorphisms are associated with psoriasis but do not determine disease response to acitretin.
Campalani E; Allen MH; Fairhurst D; Young HS; Mendonca CO; Burden AD; Griffiths CE; Crook MA; Barker JN; Smith CH
Br J Dermatol; 2006 Feb; 154(2):345-52. PubMed ID: 16433808
[TBL] [Abstract][Full Text] [Related]
4. Plexin B2 tissue expression and related gene polymorphisms in psoriasis and their relation to NB-UVB and Acitretin therapy.
Hegazy EM; Taieb MAE; Hassan MH; Ibrahim AK; El-Din EA; Ibrahim HM
Arch Dermatol Res; 2024 May; 316(5):162. PubMed ID: 38734848
[TBL] [Abstract][Full Text] [Related]
5. The combination of oral acitretin and bath PUVA for the treatment of severe psoriasis.
Muchenberger S; Schöpf E; Simon JC
Br J Dermatol; 1997 Oct; 137(4):587-9. PubMed ID: 9390336
[TBL] [Abstract][Full Text] [Related]
6. Acitretin.
Ortiz NE; Nijhawan RI; Weinberg JM
Dermatol Ther; 2013; 26(5):390-9. PubMed ID: 24099069
[TBL] [Abstract][Full Text] [Related]
7. Association of IL36RN mutations with clinical features, therapeutic response to acitretin, and frequency of recurrence in patients with generalized pustular psoriasis.
Zhu T; Jin H; Shu D; Li F; Wu C
Eur J Dermatol; 2018 Apr; 28(2):217-224. PubMed ID: 29619998
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Efficacy of Interleukin 12/Interleukin 23 Blockade in Generalized Pustular Psoriasis Regardless of IL36RN Mutation Status.
Arakawa A; Ruzicka T; Prinz JC
JAMA Dermatol; 2016 Jul; 152(7):825-8. PubMed ID: 27096382
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of acitretin in severe psoriasis.
Geiger JM
Skin Therapy Lett; 2003; 8(4):1-3, 7. PubMed ID: 12858231
[TBL] [Abstract][Full Text] [Related]
10. Erythroderma in a patient taking acitretin for plaque psoriasis.
Ahdout J; Mandel H; Chiu M
J Drugs Dermatol; 2008 Apr; 7(4):391-4. PubMed ID: 18459522
[TBL] [Abstract][Full Text] [Related]
11. Sequential therapy using cyclosporine and acitretin for treatment of total body psoriasis.
Short MW; Vaughan TK
Cutis; 2004 Sep; 74(3):185-8. PubMed ID: 15499760
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and Safety of Acitretin in Children with Plaque Psoriasis: A Multicenter Retrospective Analysis.
Di Lernia V; Bonamonte D; Lasagni C; Belloni Fortina A; Cambiaghi S; Corazza M; Di Nuzzo S; Gisondi P; Panzone M; Guarneri C; Neri I
Pediatr Dermatol; 2016 Sep; 33(5):530-5. PubMed ID: 27443789
[TBL] [Abstract][Full Text] [Related]
13. Is Oral Chinese Herbal Medicine Beneficial for Psoriasis Vulgaris? A Meta-Analysis of Comparisons with Acitretin.
Zhang CS; Yang L; Zhang AL; May BH; Yu JJ; Guo X; Lu C; Xue CC
J Altern Complement Med; 2016 Mar; 22(3):174-88. PubMed ID: 26919330
[TBL] [Abstract][Full Text] [Related]
14. Severe nail psoriasis with a rapid response to acitretin.
López V; Molina I; Martí N; Martín JM; Jordá E
Clin Exp Dermatol; 2009 Oct; 34(7):e332-3. PubMed ID: 19456766
[No Abstract] [Full Text] [Related]
15. The role of etanercept on the expression of markers of T helper 17 cells and their precursors in skin lesions of patients with psoriasis vulgaris.
Antiga E; Volpi W; Chiarini C; Cardilicchia E; Filì L; Manuelli C; Parrochi P; Fabbri P; Caproni M
Int J Immunopathol Pharmacol; 2010; 23(3):767-74. PubMed ID: 20943046
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomics on the Treatment Response in Patients with Psoriasis: An Updated Review.
Wang CY; Wang CW; Chen CB; Chen WT; Chang YC; Hui RC; Chung WH
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108492
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of total glucosides of paeony combined with acitretin in the treatment of moderate-to-severe plaque psoriasis: a double-blind, randomised, placebo-controlled trial.
Yu C; Fan X; Li Z; Liu X; Wang G
Eur J Dermatol; 2017 Apr; 27(2):150-154. PubMed ID: 28400341
[TBL] [Abstract][Full Text] [Related]
18. Treatment of severe nail psoriasis with acitretin: an impressive therapeutic result.
Ricceri F; Pescitelli L; Tripo L; Bassi A; Prignano F
Dermatol Ther; 2013; 26(1):77-8. PubMed ID: 23384024
[TBL] [Abstract][Full Text] [Related]
19. New roles for systemic retinoids.
Lebwohl M; Kathryn M
J Drugs Dermatol; 2006 May; 5(5):406-9. PubMed ID: 16703775
[TBL] [Abstract][Full Text] [Related]
20. The polymorphisms of growth factor genes (VEGFA & EGF) were associated with response to acitretin in psoriasis.
Chen W; Wu L; Zhu W; Chen X
Per Med; 2018 May; 15(3):181-188. PubMed ID: 29843550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
